8-K: FTAC Emerald Secures Extension for Business Combination, Faces Nasdaq Delisting

FTAC Emerald Acquisition Corp. has extended its business combination deadline to December 20, 2025, but will be delisted from Nasdaq and transition to the OTC market.

Summary

• FTAC Emerald Acquisition Corp. held a special meeting where stockholders approved extending the deadline to complete a business combination from December 20, 2024, to December 20, 2025.
• The company's securities will be delisted from Nasdaq due to not completing a business combination by the original deadline of December 15, 2024.
• Trading of FTAC Emerald's securities will be suspended on Nasdaq starting December 24, 2024.
• The company plans to move trading to the OTCQB Market, and if that is not possible, to the OTC Markets Pink Market.
• Despite the delisting, FTAC Emerald intends to continue pursuing its business combination with Fold, Inc.
• Holders of 112,068 public shares redeemed their shares for approximately $11.01878 per share, totaling about $1,234,852.
• Following redemptions, 4,645,816 public shares remain outstanding.
• The company's common stock ticker symbol changed from FLD to FLDD effective December 18, 2024.
• The business combination with Fold is expected to close in the first quarter of 2025.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the delisting from Nasdaq and the need for an extension, despite the continued pursuit of the business combination. The redemptions also indicate a lack of investor confidence.

Positives

• The extension of the business combination deadline provides more time to complete the merger with Fold.
• The company is actively seeking to maintain trading of its securities on the OTC market.
• The business combination with Fold is still expected to close in the first quarter of 2025.

Negatives

• The company's securities will be delisted from Nasdaq, which may negatively impact investor confidence.
• There is no guarantee that a broker will continue to make a market in the company's securities on the OTC market.
• The company has already had to extend the deadline multiple times.

Risks

• The business combination with Fold may not be completed in a timely manner or at all.
• The company may fail to obtain necessary regulatory approvals for the business combination.
• The company may not realize the anticipated benefits of the proposed transaction.
• The company's securities may not be successfully listed on the Nasdaq after the business combination.
• There is a risk of downturns and new entrants in the competitive industry in which Fold operates.
• The proposed transaction may not generate the expected net proceeds for the combined company.

Future Outlook

The business combination with Fold is expected to close in the first quarter of 2025, subject to regulatory approvals and other closing conditions. The company intends to relist on Nasdaq after the business combination.

Management Comments

• Bracebridge (Brace) Young, Jr., President and CEO of FTAC Emerald, stated that the transition to the OTC Market is a procedural measure and they expect Fold to trade on Nasdaq again after the transaction.
• Will Reeves, CEO of Fold, said that the transaction represents a significant step forward in fulfilling Folds mission and that the response to the proposed transaction has been overwhelmingly positive.

Industry Context

This announcement reflects the challenges faced by SPACs in completing business combinations within their initial timeframes. The delisting from Nasdaq and transition to the OTC market is not uncommon for SPACs that fail to meet their deadlines. The company is still pursuing a merger with a bitcoin financial services company, which is a growing sector.

Comparison to Industry Standards

• Many SPACs face challenges in completing mergers within the initial timeframe, often requiring extensions.
• Delisting from major exchanges like Nasdaq is a common consequence for SPACs that fail to meet deadlines.
• The transition to OTC markets is a typical step for companies seeking to maintain trading while addressing compliance issues.
• The redemption rate of public shares is a common metric to assess investor confidence in the SPAC's future prospects.
• The proposed merger with Fold is in line with the trend of SPACs targeting high-growth sectors like fintech and cryptocurrency.

Stakeholder Impact

• Shareholders will experience a change in trading venue from Nasdaq to the OTC market.
• Shareholders who redeemed their shares received approximately $11.01878 per share.
• The company's employees and management will continue to work towards completing the business combination.
• The company's customers and partners will be impacted by the change in trading venue and the potential for a delay in the business combination.

Next Steps

• The company will transition trading to the OTCQB Market or the OTC Markets Pink Market.
• The company will continue to pursue the business combination with Fold, Inc.
• The company will seek to relist on Nasdaq after the business combination is completed.
• The company will file a Form 25-NSE with the SEC to remove its securities from listing on Nasdaq.

Key Dates

Keywords

business combination, SPAC, delisting, Nasdaq, OTC, FTAC Emerald, Fold, merger, ticker symbol, redemption